PANACEABIO - Panacea Biotec

Panacea Biotec

PANACEABIO · Pharma > Pharmaceuticals & Drugs · Chairman: Soshil Kumar Jain · MD: Rajesh Jain · Listing date: April 18, 1996 · Employees: 2473 · New Delhi · http://www.panaceabiotec.com

Stock Price vs Company Growth

0.7%

1.9%

3.6%

65.6%

39.0%

32.2%

7.4%

10y

14.5%

all

1.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 533 0.7%

314

648

Company Overview

Sales

640 Cr

Growth: 2.7%

Profit after Tax

-24.9 Cr

Growth: -52.4%

Small Cap

3,267 Cr

P/S: 5.1x

Industry P/S: 2.7x

Fundamentals

Sales (Cr)	₹ 640
Growth	2.7%
EBITDA	-0.7%
P/S	5.1x
Dividend	0.0%
P/E	-608.6x
Book Value	₹ 136
PEG Ratio	-225.0x
ROE	-3.0%
P/B	3.9x

Shareholding Pattern

Institutions

Serum Institute Of India Pvt Ltd

8.59 %

Promoters

Dr. Rajesh Jain

41.17 %

Sandeep Jain

16.38 %

Soshil Kumar Jain

8.16 %

Nirmala Jain

4.1 %

First Lucre Partnership Co.

3.68 %

Others

Ifpf

0.18 %

Increase Decrease No change

Company Profile Detailed

The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.Panacea Biotec is the third largest biotechnology company (as per ABLE Survey, 2006), as well as among the top 50 pharmaceutical companies (as per ORG IMS July 2006) of India.The company has been granted patents across countries like USA, U.K.

Belongs to (4 Indices)

Investors (51)

icici.pr...

sunanda....

ohm.inve...

Followers (5)

bhaskar6

zest

piresh